Pfizer | PFE

Stock Price
28.84
Daily Change
0.46 1.62%
Monthly
12.22%
Yearly
-22.08%
Q2 Forecast
25.31
Peers Price Chg Day Year Date
AbbVie 164.21 2.59 1.60% 14.60% May/15
Abbott 104.25 0.76 0.73% -4.70% May/15
ALKERMES 24.24 -0.25 -1.02% -21.86% May/15
Amgen 319.14 7.28 2.34% 40.05% May/15
AstraZeneca 12,172.00 -74.00 -0.60% 0.85% May/15
Bayer 29.33 0.11 0.36% -45.34% May/15
Biogen 235.43 8.30 3.65% -23.46% May/15
Bristol-Myers Squibb 44.61 -0.19 -0.42% -33.44% May/15
Catalent 55.65 0.13 0.23% 67.66% May/15
Gilead Sciences 67.00 -0.66 -0.97% -14.45% May/15
GlaxoSmithKline 1,812.50 2.50 0.14% 23.64% May/15
Glaxosmithkline 45.70 0.04 0.09% 25.31% May/15
J&J 152.68 1.24 0.82% -4.18% May/15
Eli Lilly 787.02 22.84 2.99% 80.24% May/15
Medtronic 84.95 0.42 0.50% -4.44% May/15
Merck 131.77 3.08 2.39% 13.52% May/15
Neurocrine Biosciences 142.00 3.52 2.54% 50.54% May/15
Novartis 93.30 -0.19 -0.20% 0.86% May/15
Novartis 103.13 -0.24 -0.23% 0.31% May/15
Prestige Brands 66.46 -5.01 -7.01% 12.66% May/15
Pacira 30.08 -0.74 -2.40% -27.11% May/15
Pfizer 28.84 0.46 1.62% -22.08% May/15
Perrigo 30.26 -0.09 -0.30% -7.87% May/15
Drreddys Laboratories 69.65 -0.02 -0.03% 26.29% May/15
Regeneron Pharmaceuticals 978.21 -7.20 -0.73% 31.78% May/15
Roche Holding 227.50 2.90 1.29% -19.41% May/15
Sanofi 90.56 -1.13 -1.23% -9.75% May/15
Sanofi 49.00 -0.51 -1.03% -10.18% May/15
Vertex Pharmaceuticals 437.40 8.63 2.01% 26.73% May/15
Zoetis 173.12 4.33 2.57% -4.59% May/15

Indexes Price Day Year Date
US500 5310 61.47 1.17% 27.69% May/16

Pfizer traded at $28.84 this Wednesday May 15th, increasing $0.46 or 1.62 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 12.22 percent. Over the last 12 months, its price fell by 22.08 percent. Looking ahead, we forecast Pfizer to be priced at 25.31 by the end of this quarter and at 24.34 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.